Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and development, and clinical trials leveraging pharmacoproteomics With Bruker investments, Biognosys plans to open advanced US proteomics CRO facility for proteomics biomarker and drug... Read more

GE Announces Total Consideration and Amounts Accepted in its Debt Tender Offer: Expects to Repurchase Approximately $7.2 Billion in Principal Amount on December 2, 2022

Accepted Tender Amounts: As previously announced, a total of approximately $9.3 billion in principal amount of the Securities denominated in U.S. dollars, approximately £629 million in principal amount of the Securities denominated in Pounds Sterling, and approximately €865 million in principal amount of the Securities denominated in Euros, each listed in the table below were... Read more

Promoting Development and Commercialization of Innovative Technologies Through Collaboration Between Industry and AcademiaComprehensive Collaborative Agreement Signed with Kyoto University Aiming at Creating New Business Activities

Promoting Development and Commercialization of Innovative Technologies Through Collaboration Between Industry and AcademiaComprehensive Collaborative Agreement Signed with Kyoto University Aiming at Creating New Business Activities Read more

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation WASHINGTON, Nov. 10, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacons is a... Read more

Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2022 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the Company on Tuesday, November 15, 2022 at 12:00 PM Eastern Time.... Read more